SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001144204-18-007326
Filing Date
2018-02-12
Accepted
2018-02-12 16:15:50
Documents
1
Group Members
JULIET TAMMENOMS BAKKERLONGITUDE VENTURE PARTNERS II, L.P.PATRICK G. ENRIGHT

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tv485365_sc13ga.htm SC 13G/A 76358
  Complete submission text file 0001144204-18-007326.txt   78103
Mailing Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884
Business Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884 (650) 614-5220
Aimmune Therapeutics, Inc. (Subject) CIK: 0001631650 (see all company filings)

IRS No.: 452748244 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88972 | Film No.: 18596538
SIC: 2834 Pharmaceutical Preparations

Mailing Address 800 EL CAMINO REAL SUITE 220 MENLO PARK CA 94025
Business Address 800 EL CAMINO REAL SUITE 220 MENLO PARK CA 94025 650-854-5700
Longitude Capital Partners II, LLC (Filed by) CIK: 0001647491 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A